ResMed | RMD - Net Income

Stock Price
263.03
Daily Change
11.62 4.62%
Monthly
7.20%
Yearly
8.43%
Q1 Forecast
250.35

ResMed reported $392.59M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Ansell USD 23.3M 33.8M Jun/2025
AtriCure USD -267K 5.92M Sep/2025
Baxter International USD -46M 137M Sep/2025
Cochlear AUD 91.9M 113.2M Jun/2025
Cooper Companies USD 84.6M 13.7M Sep/2025
CSL USD 497.5M 1.51B Jun/2025
Dexcom USD 179.8M 74.4M Jun/2025
Edwards Lifesciences USD 291.1M 42.1M Sep/2025
Fisher Paykel Healthcare NZD 213M 11M Dec/2025
Globus Medical USD 118.97M 83.88M Sep/2025
Haemonetics USD 38.68M 4.65M Sep/2025
Hologic USD 179.1M 8.2M Dec/2025
Idexx Laboratories USD 248.19M 26.42M Dec/2025
Insulet USD 87.6M 65.1M Sep/2025
Integra LifeSciences USD -5.4M 478.67M Sep/2025
Intuitive Surgical USD 794.8M 90.4M Dec/2025
Masimo USD -100.4M 151.7M Sep/2025
Medtronic USD 1.37B 334M Sep/2025
Philips EUR 184M 56M Sep/2025
Ramsay Health Care AUD 120.3M 225.2M Jun/2025
ResMed USD 392.59M 44.06M Dec/2025
Sigma Healthcare AUD -6.72M 10.02M Dec/2024
Sonic Healthcare AUD 236.68M 82.29M Dec/2024
Steris USD 191.9M 14.5M Sep/2025
Teleflex USD -408.89M 531.47M Sep/2025
Thermo Fisher Scientific USD 1.96B 348M Dec/2025